Resalis Therapeutics
PrivateLast Round
Strategic
Oct 28, 2024
Total Funding Raised
$21.71M
Company Overview
Resalis Therapeutics is a biotechnology company developing non-coding RNA-based therapies for metabolic disorders such as obesity and fatty liver disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resalis Therapeutics Comparables
Compare Resalis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AptamiR Therapeutics | 87% | |
| Rivus Pharmaceuticals | 78% | |
| EraCal Therapeutics | 75% | |
Resalis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 28, 2024 | ||||
| Series A | Jan 4, 2024 | ||||
| Seed | Feb 22, 2023 |
Key People
Founding team and executive leadership
Resalis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Club degli Investitori | Seed, Series A |
| Claris Ventures | Series A, Seed |
| Sunstone Life Science Ventures | Series A |
| Italian Angels for Growth | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2024
Sanofi led a strategic funding round.
- Jan 4, 2024
$11M round led by Sunstone Life Science Ventures.
Resalis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resalis Therapeutics's valuation, stock price, and market status.